Lucid Diagnostics Inc. (LUCD)
NASDAQ:LUCD
Want to see LUCD full AI Analyst Report?
Earnings Data
Report Date
Aug 17, 2026After Close (Confirmed)
Period Ending
2026 (Q2)Consensus EPS Forecast
-0.06Last Year’s EPS
-0.1Same Quarter Last Year
Strong Buy
Based on 5 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Neutral
The call conveyed a mix of constructive commercial and balance-sheet progress (test volume above targets, LBM policy secured, VA contract and initial PO, strengthened pro forma cash position, favorable draft guideline mention) alongside material near-term reimbursement and collection challenges (Medicare LCD delays, conservative revenue recognition practices, adjudication volatility and denials, elevated burn rate). Management expressed confidence and has positioned to scale once Medicare coverage is issued, but the company currently faces meaningful timing and cash-collection risk that keeps fundamentals mixed.Company Guidance
Solid Test Volume
Performed 3,177 EsoGuard tests in Q1 2026 (reported as 'almost 3,200'), which is above the company's stated pre-Medicare target range of 2,500–3,000 tests.
Billable Value vs. Recognized Revenue
Q1 billable value at list price ($27.49) was over $8.7 million; recognized revenue was $1.3 million (approximately 14% of billable value) reflecting current reimbursement/collection accounting practices.
Balance Sheet Strengthening
Completed an underwritten public offering with approximately $16.8 million in proceeds; cash at March 31 was $27.9 million and pro forma cash after the April 24 financing was $44.8 million (stated as ~ $45M), extending runway into 2027.
VA Federal Supply Schedule Contract & Initial PO
Placed on the Federal Supply Schedule with a contracted payment rate equal to the Medicare rate ($1,938); the company has received an initial PO and expects to begin VA testing and revenue generation in the near term. The VA opportunity covers ~9 million veterans.
First Laboratory Benefit Manager Coverage Policy Secured
Secured its first positive coverage policy with a laboratory benefit manager (LBM); policy is expected to be publicly announced in the coming weeks and could drive downstream payer policies.
Operational Expense Discipline
Non-GAAP operating expenses for the quarter were $11.7 million, essentially in line with the 5-quarter average of $12.0 million (~2.5% below the average). Total OpEx was generally flat year-over-year and sequential OpEx decreased about $2.0 million versus Q4 (mostly lower G&A and one-time Q4 items).
Improved Non-GAAP EPS Trend
Non-GAAP net loss per share was $0.07 in Q1, an improvement of about $0.03 versus each of the prior three quarters.
Clinical & Guideline Momentum
Strong reception at DDW (company described it as its best conference ever). AGA draft guideline preview cited EsoGuard (and EsoCheck) by name and rated the evidence as high certainty in this preview — a potential commercial and payer-engagement catalyst. Ongoing clinical work includes institutional studies, a registry, and an active NIH study.
LUCD Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
LUCD Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 14, 2026 | $1.02 | $1.02 | 0.00% |
Mar 26, 2026 | $1.19 | $1.15 | -3.36% |
Nov 12, 2025 | $1.04 | $1.11 | +6.73% |
Aug 13, 2025 | $1.00 | $0.98 | -2.00% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Lucid Diagnostics Inc. (LUCD) report earnings?
Lucid Diagnostics Inc. (LUCD) is schdueled to report earning on Aug 17, 2026, After Close (Confirmed).
What is Lucid Diagnostics Inc. (LUCD) earnings time?
Lucid Diagnostics Inc. (LUCD) earnings time is at Aug 17, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is LUCD EPS forecast?
LUCD EPS forecast for the fiscal quarter 2026 (Q2) is -0.06.